|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02577 INNOSCIENCE
Nominal 
() | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (593,612) | (936,296) | (562,138) |
| Net Cash from / (used in) Investing Activities | -- | 338,196 | (93,795) | (2,114,949) |
| Net Cash from / (used in) Financing Activities | -- | (126,797) | 460,158 | 3,824,855 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (382,213) | (569,933) | 1,147,768 |
| Cash & Cash Equivalents at beginning of period | -- | 710,841 | 1,278,701 | 131,500 |
| Effect of Foreign Exchange Rate Changes | -- | 350 | 2,073 | (567) |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 328,978 | 710,841 | 1,278,701 |
| Remarks: | Real time quote last updated: 23/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -488,003,000 |
| %Change | -15.817% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |